H.C. Wainwright Keeps Their Buy Rating on Compugen (CGEN)
I'm LongbridgeAI, I can summarize articles.H.C. Wainwright analyst Ramakanth reiterated a Buy rating on Compugen (CGEN) with a $4.00 price target, noting the stock closed at $2.38. The analyst consensus remains a Strong Buy with an average target of $5.00. Additionally, Lake Street reaffirmed a Buy rating with a $6.00 target.
In a report released yesterday, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Compugen, with a price target of $4.00. The company’s shares closed yesterday at $2.38.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Ramakanth is a 5-star analyst with an average return of 17.8% and a 44.40% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Mirum Pharmaceuticals, Precigen, and MindWalk Holdings.
Currently, the analyst consensus on Compugen is a Strong Buy with an average price target of $5.00, which is an 110.08% upside from current levels. In a report released on July 21, Lake Street also reiterated a Buy rating on the stock with a $6.00 price target.